3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
4
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurocognitive Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Nivolumab
1
Linear Energy Transfer
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Observation
×
30 days
×
Clear all
No trials found.